Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and erbb2

Genes Chromosomes and Cancer

Volumn 23, Issue 4, 1998, Pages 307-316

  Nessling, Michelle ^a   Solinas Toldo, Sabina ^a   Wilgenbus, Klaus K ^b   Borchard, Franz ^c   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 16P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031735293     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199812)23:4<307::aid-gcc5>3.0.co;2-%23     Document Type: Article

References (63)

1. Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, Tahara E (1996) Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jap J Cancer Res 87:824-830.
2. Alitalo K, Schwab M (1986) Oncogene amplification in tumor cells. In Klein G, Weinhouse S (eds): Advances in Cancer Research. Orlando, FL: Academic Press, pp 235-281.
3. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi Q-P, Trent JM, Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
4. Bara J, Hamelin L, Martin E, Burtin P (1981) Intestinal M3 antigen, a marker for the intestinal-type differentiation of gastric carcinomas. Internation J Cancer 28:711-719.
5. Bentz M, Döhner H, Huck K, Schütz B, Ganser A, Joos S, du Manoir S, Lichter P (1995) Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 12:193-200.
6. Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schröder M, Stilgenbauer S, Fischer K, Möller P, Lichter P (1996) High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88:1437-1444.
7. Beroud C, Soussi T (1996) APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucl Acids Res 24:121-124.
8. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
9. Chan AM-L, Hilkens J, Kroezen V, Mitchell PJ, Scrambler P, Wainwright BJ, Williamson R, Cooper CS (1989) Molecular cloning and localization to chromosome 6 of mouse INT1L1 gene. Somatic Cell Molec Genetics 15:555-562.
10. Chen Y-J, Chang J-G, Shih L-S, Chen P-H, Endo M, Whang-Peng J, Chen Y-MA (1997) Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Internat J Cancer 71:350-354.
11. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA (1987) ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178-182.
12. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Human Genetics 90:590-610.
13. Du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
14. El-Rifai W, Harper JC, Cummings OW, Hyytinen E-R, Frierson HFJ, Knuutila S, Powell SM (1998) Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 58:34-37.
15. Ferti-Passantonopoulou AD, Panani AD, Vlachos JD, Raptis SA (1987) Commun cytogenetic findings in gastric cancer. Cancer Genet Cytogenet 24:63-73.
16. Findlay M, Cunningham D (1955) Gastric cancer. In Horwich A (ed): Oncology. London: Chapman & Hall, pp 635-650.
17. Fukushige S-I, Matsubara K-I, Yoshida M, Sasaki M, Suzuki T, Semba K, Toyoshima K, Yamamoto T (1986) Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Molec Cell Biol 6:955-958.
18. Fuller GN, Bigner SH (1992) Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Res 276:299-306.
19. Garson JA, McIntyre PG, Kemshead JT (1985) N-MYC amplification in malignant astrocytoma. Lancet 8457:718-719.
20. Gazdar AF, Carney DN, Nau MM, Minna JD (1985) Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45:2924-2930.
21. Genome Data Base G (1997) The Human Genome Data Base Project Baltimore: Johns Hopkins University. Updated daily. Available from Internet: URL: http//:gdbwww.gdb.org/.
22. Hermanek P, Sobin LH (1992) TNM Classification of Malignant Tumours. Berlin: Springer-Verlag.
23. Houldsworth D, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K, Chaganti RSK (1996) Rel protooncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87:25-29.
24. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P (1993) Detection of amplified genomic sequences by reverse chromosome painting using genomic tumor DNA as probe. Human Genetics 90:584-589.
25. Joos S, Otano-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P (1996) Primary mediastinal (thymic) B-cel lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1371-1578.
26. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
27. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
28. Kohl NE, Gee CE, Alt FW (1984) Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 226:1335-1337.
29. Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso K, Knuutila S (1997) 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: A comparative genomic hybridization study. Genes Chromosomes Cancer 20:38-43.
30. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189:227-232.
31. Kushima R, Lohe B, Borchard F (1996) Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas. Histopathology 29:443-148.
32. Lammie GA, Peters G (1991) Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420.
33. Laurén P (1965) The two histological main types ot gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31-49.
34. Lee W-H, Murphree AL, Benedict WF (1984) Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309:458-460.
35. Lichter P, Umeda PK, Levin JE, Vosberg H-P (1986) Partial characterization of the human β-myosin heavy-chain gene which is expressed in heart and skeletal muscle. Europ J Biochem 160:419-426.
36. Lichter P, Bentz M, Joos S (1995) Detection of chromosomal aberrations by means of molecular cytogenetics: Painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Meth Enzymol 254:334-359.
37. Nau MM, Brooks BJJ, Carney DN, Gazdar AF, Battey JF, Sausville EA, Minna JD (1986) Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Nat Acad Sc USA 83:1092-1096.
38. Nielsen J, Aagaard J, Toftgaard C (1985) Gastric cancer with special reference to prognostic factors: A review of 779 cases. Acta Chirurg Scand 151:49-55.
39. Ochi H, Douglass HOJ, Sandberg AA (1986) Cytogenetic studies in primary gastric cancer. Cancer Genet Cytogenet 22:295-307.
40. Park J-B, Rhim JS, Park S-C, Kimm S-W, Kraus MH (1989) Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Research 49:6605-6609.
41. Parkin DM (1994) Cancer in developing countries. Cancer Surveys 19-20:519-561.
42. Rege-Cambrin G, Scaravaglio P, Carozzi F, Giordano S, Ponzetto C, Comoglio PM, Saglio G (1992) Karyotypic analysis of gastric carcinoma cell lines carrying an amplified c-met oncogene. Cancer Genet Cytogenet 64:170-173.
43. Rodriguez E, Rao PH, Ladanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC, Chaganti RSK (1990) 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res 50:6410-6416.
44. Saal K, Vollmers HP, Müller J, Köhler J, Höhn H, Müller-Hermelink HK (1993) Cytogenetic differences between intestinal and diffuse types of human gastric carcinoma. Virchows Arch B Cell Pathol 64:145-150.
45. Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R (1997) Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chromosomes Cancer 18:318-321.
46. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
47. Schütz BR, Scheurlen W, Krauss J, du Manoir S, Joos S, Bentz M, Lichter P (1996) Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 16:196-203.
48. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene 159:83-96.
49. Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248.
50. Sen S, Zhou H, White RA (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpresscd in human breast cancer cell lines. Oncogene 14:2195-2200.
51. Seruca R, Castedo S, Correia C, Gomes P, Carneiro F, Soares P, De Jong B, Sobrinho-Simoes M (1993) Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet 68:42-18.
52. Seruca R, Suijkerbuijk RF, Gärtner F, Criado B, Veiga I, Olde-Weghuis D, David L, Castedo S, Sobrinho-Simoes M (1995) Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet 82:140-145.
53. Solinas-Toldo S, Wallrapp C, Müler-Pillasch F, Bentz M, Gress T, Lichter P (1996) Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807.
54. Solinas-Toldo S, Dürst M, Lichter P (1997) Specific chromosomal imbalances in human papillomavirus-transfected cells during progression towards immortality. Proc Nat Acad Sci USA 94:3854-3859.
55. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265-272.
56. Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K, Satodate R (1996a) Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 56:612-615.
57. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Terashima M, Eda Y, Satodate R (1996b) Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180:371-377.
58. Tatematsu M, Furihata C, Katsuyama T, Miki K, Honda H, Konishi Y, Ito N (1986) Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 46:4866-4872.
59. Tsujino T, Yoshida K, Nakayama H, Ito H, Shimosato T, Tahara E (1990) Alterations of oncogenes in metastatic tumours of human gastric carcinomas. Brit J Cancer 62:226-230.
60. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics 9:401-106.
61. Werner CA, Döhner H, Joos S, Trümper LH, Baudis M, Barth TFE, Ott G, Möller P, Lichter P, Bentz M (1997) High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 151:335-342.
62. Xiao S, Geng J-S, Feng X-L, Liu X-Q, Liu Q-Z, Li P (1992) Cytogenetic studies of eight primary gastric cancers. Cancer Genet Cytogenet 58:79-84.
63. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T (1988) Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2:283-287.